Ana Sayfa › Akut Miyeloid Lösemi › North Carolina › Durham
Durham, NC içinde Akut Miyeloid Lösemi klinik çalışmaları
Akut Miyeloid Lösemi için 33 çalışma, Durham ve çevresindeki (yaklaşık 30 mil mesafedeki) merkezlerde katılımcı arıyor. Kimlerin katılabileceğini ve çalışma ekibine nasıl ulaşılacağını görmek için bir çalışmayı açın.
Resmi çalışma metni (İngilizce)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Katılımcı aranıyorEvre 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mil uzakta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Katılımcı aranıyorGözlemsel çalışmaSağlıklı gönüllüler kabul ediliyor
- Durham VA Medical Center, Durham
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Katılımcı aranıyorEvre 2
- Duke University Medical Center, Durham
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Katılımcı aranıyorEvre 2
- Duke University Medical Center, Durham
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Katılımcı aranıyorEvre 2
- Duke University Medical Center, Durham
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Katılımcı aranıyorEvre 2
- Duke University Medical Center, Durham
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Katılımcı aranıyorEvre 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mil uzakta
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Katılımcı aranıyorEvre 1/2
- Duke University Medical Center, Durham
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Katılımcı aranıyorEvre 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mil uzakta
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Katılımcı aranıyorEvre 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mil uzakta
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Katılımcı aranıyorEvre 3
- US-Chapel Hill-UNCNORTHCAROLINA, Chapel Hill · 10 mil uzakta
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Katılımcı aranıyorEvre 1/2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mil uzakta
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Katılımcı aranıyorEvre 1
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mil uzakta
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Katılımcı aranıyorEvre 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 10 mil uzakta
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Katılımcı aranıyorEvre 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mil uzakta
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Katılımcı aranıyorEvre 1/2
- Research Site, Durham
- Research Site, Chapel Hill · 10 mil uzakta
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Katılımcı aranıyorEvre 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mil uzakta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Katılımcı aranıyorGözlemsel çalışma
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mil uzakta
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Katılımcı aranıyor
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mil uzakta
Registry of Older Patients With Cancer
Katılımcı aranıyorGözlemsel çalışma
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mil uzakta
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
Katılımcı aranıyorEvre 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mil uzakta
A Study of Revumenib and Mezigdomide in People With Leukemia
Katılımcı aranıyorEvre 1/2
- University of North Carolina (Data Collection Only), Chapel Hill · 10 mil uzakta
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
Katılımcı aranıyorEvre 1
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mil uzakta
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Katılımcı aranıyorEvre 1
- University of North Carolina, Chapel Hill · 10 mil uzakta
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Katılımcı aranıyorEvre 2/3
- Duke University, Durham
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Katılımcı aranıyorEvre 1/2
- Duke University, Durham
- UNC Hospital, Chapel Hill · 10 mil uzakta
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Katılımcı aranıyorEvre 2
- University of North Carolina, Chapel Hill · 10 mil uzakta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Katılımcı aranıyorEvre 1
- Duke Blood Cancer Center, Durham
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Katılımcı aranıyorEvre 1
- Duke Cancer Center, Durham
Novel Digital Application for Patients With Acute Leukemia
Katılımcı aranıyor
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Katılımcı aranıyorGözlemsel çalışma
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mil uzakta
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Katılımcı aranıyorEvre 1/2
- Duke University Medical Center, Durham
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Katılımcı aranıyorSağlıklı gönüllüler kabul ediliyor
- Duke University, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mil uzakta
Diğer şehirlerde Akut Miyeloid Lösemi çalışmaları
- Houston, TX85 çalışma
- New York City, NY51 çalışma
- Boston, MA44 çalışma
- Seattle, WA41 çalışma
- Baldwin Park, CA40 çalışma
- Columbus, OH35 çalışma
- Philadelphia, PA34 çalışma
- Atlanta, GA31 çalışma
- Tampa, FL29 çalışma
- Chicago, IL26 çalışma
- Portland, OR25 çalışma
- Washington, DC24 çalışma
Durham içinde diğer çalışmalar
- Meme Kanseri64 çalışma
- Kanser (tüm türler)58 çalışma
- Küçük Hücreli Olmayan Akciğer Kanseri39 çalışma
- Multiple Miyelom37 çalışma
- Metastatik Kanser33 çalışma
- Prostat Kanseri32 çalışma
- Akciğer Kanseri32 çalışma
- Kolorektal Kanser28 çalışma
- Yumurtalık Kanseri27 çalışma
- Kronik Lenfositik Lösemi27 çalışma
- Kalp Yetmezliği26 çalışma
- Pankreas Kanseri24 çalışma
ClinicalTrials.gov'dan alınmıştır, veri tarihi: 6 Eki 2026. Her çalışma kendi uygunluk kriterlerini belirler; katılım kararı çalışma ekibine aittir.